 that the risk of periprocedural events after CEA or CAS might be increased
in patients presenting with severe comorbid conditions,
including dialysis-dependent renal failure, New York
Heart Association functional class III or IV heart disease, a
left ventricular ejection fraction of less than 30%, class III
or IV angina pectoris, left main or multivessel coronary
disease, severe aortic valvular disease, oxygen- or steroiddependent pulmonary disease